Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

BROOMFIELD, Colo., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced the appointment of Dan Isherwood as UK Commercial Director.

Read more at globenewswire.com